Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China/Guangdong, China
Contact: Study coordinator (Yajin Chen) · cyj0509@126.com · 13719006202
Contact: Study coordinator (Changzhen Shang) · shangchangzhen@139.com · 13711279678

Study leads

Yajin Chen
Study Director
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Chengdu, China

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China · Hanzhou, China